http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31850776

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase I|Journal Article|Research Support, Non-U.S. Gov't
endingPage 20
issn 1532-1827
0007-0920
issueIdentifier 1
pageRange 15-20
publicationName British Journal of Cancer
startingPage 15
bibliographicCitation O'Byrne KJ, Thomas AL, Sharma RA, DeCatris M, Shields F, Beare S, Steward WP. A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer. British Journal of Cancer. 2002 Jun 25;87(1):15–20. doi: 10.1038/sj.bjc.6600344.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d90050e758df6dfe9ba744f9e0f4e2dc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c405a5907a8f7f9feeafd9d936543c39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a28ef324a4a5347c4c3ddea0626d1e24
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_797c6331422adbb66d2a8979cdabd00e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_787f8ac35e7cfb38f973d56f0e1d26b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af3607a095d355e36821e6c46407f48d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ef13eef1e686b163f2ec93631991030
date 2002-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2364277
https://pubmed.ncbi.nlm.nih.gov/12085249
https://doi.org/10.1038/sj.bjc.6600344
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
https://portal.issn.org/resource/ISSN/1532-1827
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer
discusses http://id.nlm.nih.gov/mesh/M0012600
http://id.nlm.nih.gov/mesh/M0005683
http://id.nlm.nih.gov/mesh/M0001348
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62770
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9961878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11499
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128658409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135935977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129674956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135944557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129347572

Total number of triples: 58.